Thursday, November 19, 2009
Many people associate Luxembourg with the banking industry, i.e., local and global financial institutions. However, that small country located in Northwest Europe recently embarked upon something completely different—the establishment of a biobank. The independent and not-for-profit Integrated Biobank of Luxembourg (IBBL) plans to collect, store, analyze, and redistribute biospecimens while preserving the confidentiality of the donor's data. How the IBBL plans to do this is the subject of today’s podcast.
During this GEN podcast, Dr. Robert Hewitt talks about the rationale for creating the biobank and the path his team took in setting its goals. He discusses what Luxembourg has to offer in terms of biotechnology expertise and gives us the specifics about his plans for gaining increasing international recognition for the IBBL.
Dr. Hewitt also goes into the role played by the Phoenix, Arizona-based Translational Genomics in encouraging the formation of IBBL and explains the nature of IBBL’s collaborative research arrangements with Dr. Leroy Hood from the Institute of Systems of Biology in Seattle and Dr. Leland Hartwell of the Partnership for Personalized Medicine in Phoenix.
NOTICE: As such, the comments on this blog were, are, and will always be solely the opinions of the individuals leaving them. In no way does Genetic Engineering & Biotechnology News, GEN Publishing, Inc., or Mary Ann Liebert ,Inc. endorse, condone, agree with, sponsor, etc. these comments.
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
HOME
Hot Topics
All Topics
Archived
Post a Topic
RSS
LISTEN
COMMENT
Email
Print
Back
Share
Save